Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Medical - Devices

Healthcare
$1.20 -6.72%

-$0.09 today

Market cap
$50.65M
Beta
-1.23
P/E (TTM)
-1.3
EPS (TTM)
-$0.94
52W Low $0.76High $7.26

Volume 0.02M

Average 0.37M

BDMD Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

Baird Medical Investment Holdings LimitedNASDAQ: BDMD

Net Receivables · Q4 FY2025 · quarter ended Dec 2025

Net receivables falls 8.7% from a year ago

Net receivables stood at $42.53M at the end of Q4 FY2025, down 8.7% from a year earlier. Over 3 fiscal years it compounded at +19.8% a year.

Context

  • Net receivables amounted to 61.0% of total assets at the end of Q4 FY2025, up 1.3 pp from a year earlier.
  • Net receivables increased in 2 of the last 3 fiscal years.

What to watch

Whether net receivables keeps falling in the next quarterly balance sheet after a -8.7% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterDec 2025
$42.53M— QoQ
Last fiscal yearDec 2025
$42.53M-8.7% YoY
Year agoDec 2024
$46.58M-8.7% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-8.7%——
1 year-8.7%——
3-year CAGR+19.8%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
42.53M USD
Year-over-year change
-8.7%
4-year CAGR
+36.0%

Net Receivables vs competitors

How BDMD compares with its peers on the latest reported figures

  • BDMD's Dec 2025 net receivables of $42.53M is the highest of the 4 companies compared; the peer median is $872K.
  • Its year-over-year change of -8.7% is the 2nd highest of 3, against a peer median of -7.9%.
  • Net receivables amounts to 61.0% of total assets for BDMD, versus a peer median of 5.6%.
BDMD Competitors Peer median
Net Receivables for BDMD and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
BDMDBaird Medical Investment Holdings LimitedDec 2025$42.53M -8.7%+19.8%61.0%
BDSXBiodesix, Inc.Mar 2026$9.5M +24.4%+21.3%10.0%
ECORelectroCore, Inc.Mar 2026$872K -40.2%+36.8%5.6%
OKUROnKure Therapeutics, Inc.Mar 2026$0 ——0.0%
Peer median (excluding BDMD) $872K-7.9%+29.1%5.6%

Competitors are the stored peer set for BDMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents3.03M1.71M1.51M2.97M178.32K
Short-term Investments407.5K197K120.49K00
Net Receivables12.45M24.76M31.49M46.58M42.53M
Inventory3.06M1.29M1.14M1.3M1.09M
Other Current Assets304.29K197K120.49K295.75K628.04K
Total Current Assets22.4M33.76M40.08M61.42M54.97M
Property, Plant & Equipment (Net)3.33M2.73M7M7.62M6.55M
Goodwill66.17K61.14K59.38K57.77K60.3K
Intangible Assets62.77K49.48K25.48K16.53K8.63K
Long-term Investments(108.15K)(206.22K)(814.37K)00
Tax Assets79.78K206.22K1.63M714.46K762.29K
Other Non-current Assets190.08K5.81M10.36M8.14M7.35M
Total Non-current Assets3.72M8.85M16.63M16.55M14.73M
Total Assets26.12M42.62M56.71M77.96M69.7M
Account Payables340.21K215.86K550.19K1.25M1.81M
Short-term Debt2.04M6.23M8.17M17.03M13.07M
Tax Payables739.4K1.8M770.95K2.87M3.1M
Deferred Revenue701.53K692.51K499.91K792.1K793.41K
Other Current Liabilities29.91K20.32K93.39K45.24K8.76K
Total Current Liabilities9.77M16.02M18.98M34.62M32.36M
Long-term Debt0003.44M6.09M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities001.61M00
Total Non-current Liabilities494.12K816.88K2.03M3.58M6.11M
Total Liabilities10.26M16.84M21M38.2M38.48M
Common Stock11.64K2.94K2.94K2.56K3.08K
Retained Earnings(7.13M)3.96M14.39M26.76M(515.42K)
Accumulated OCI3.31M3.12M2.5M1.45M3.22M
Other Stockholders Equity(9.84M)0000
Minority Interest(356.73K)(155.59K)(43.39K)101.34K(144.09K)
Total Equity4.85M25.78M35.71M39.76M31.22M
Total Debt2.93M7.44M9.9M20.88M19.3M
Net Debt(97.6K)5.73M8.39M17.91M19.12M

Baird Medical Investment Holdings Limited

NASDAQ:BDMD

Intrinsic Alpha fair value

Locked

Current Price

$1.20

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.